Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation has been reported in the published literature.
No clinical trials have been registered for familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation.
5 publications have been identified in PubMed for familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation. Research spans Review / Meta-Analysis (40%), Diagnostic / Biomarker (20%), and Case Report / Case Series (20%).
Lal K (2026). [PMID: 41824887](https://pubmed.ncbi.nlm.nih.gov/41824887/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Román Ortiz E (2026). [PMID: 41361594](https://pubmed.ncbi.nlm.nih.gov/41361594/). *Pediatr Nephrol*. [Case Report / Case Series]
Kamei K (2025). [PMID: 40473980](https://pubmed.ncbi.nlm.nih.gov/40473980/). *Pediatr Nephrol*. [Diagnostic / Biomarker]
Taş Ö (2025). [PMID: 40455313](https://pubmed.ncbi.nlm.nih.gov/40455313/). *Clin Rheumatol*. [Review / Meta-Analysis]
Ichikawa Y (2024). [PMID: 39093455](https://pubmed.ncbi.nlm.nih.gov/39093455/). *Pediatr Nephrol*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 8:14 PM UTC
European rare disease database